S D'Silva, V Borse, RB Colah… - Genetic Testing and …, 2011 - liebertonline.com ... B ilirubin is a potent antioxidant with clinically relevant protective effects; however, it could also be toxic. Serum bilirubin is primarily derived from hemoglobin, which is broken down into heme and globin. Heme oxygenase (HMOX ... Related articles - All 2 versions
RT Maziarz… - Blood and Marrow Transplant Handbook, 2011 - Springer ... in the u pper-third o f the esophagus Pancreatic insuffi ciency Anorexia Nausea Vo m itin g Diarrhea W e ight loss Failure to thrive Liver T o tal b ilirubin, a lk phos > 2 × ULN AL T o r A ST >2 × ULN Lung Bronchiolitis o bliterans diagnosed with lung biopsy Bronchiolitis ... Related articles
S Ruiz‐Gaspà, A Martinez‐Ferrer… - …, 2011 - Wiley Online Library ... 14 13- Duff TA, Feilbach JA, Yusuf Q, Scott G. Bilirubin and the induction of intracranial arterial spasm. J Neurosurg. ... 21- Vassilopoulou-Sellin R, Rey-Bear N, Oyedeji CO. Bilirubin as an inhibitor of cartilage metabolism: effect on avian chondrocyte proliferation in cell culture. ...
[HTML] from mayoclinicproceedings.comSJ Bielinski, HS Chai, J Pathak… - Mayo Clinic …, 2011 - mayoclinicproceedings.com ... institution. Further, the DUA outlines the procedures for amending a current agreement and specifies how the failure to comply with the terms of the DUA will be addressed. Bilirubin Phenotype—A GWA Application. For phase ... Cited by 2 - Related articles - All 5 versions
E Lawitz, E Godofsky, R Rouzier, T Marbury… - Antiviral research, 2011 - Elsevier ... mg bid 400mg bid 600 mg bid Day 0 Day 14 Log HCV RNA Page 27 of 29 Accepted Manuscript 27 Figure 2 A. NIM811 B. p < .01 p < 0.01 p < 0.01 p < .01 ALT ( IU / m L ) ALT ( IU / m L ) Page 28 of 29 Accepted Manuscript 28 Figure 3 A. NIM811 B. p <0.01 B ilirubin ( mol ) B ... All 3 versions